Oncotarget · 2015 · 177 citations · 11 references
MedicineMolecular GeneticsOncologyApoptosisGene ExpressionMolecular OncologyApoptosis In CancerCancer GenomicsCancer TranscriptomicsColorectal CancerNoncoding Rna In CancerTumor Suppressor GenesLong Non-coding Ribonucleic AcidsLong Noncoding Rna Expression AnalysisLong Noncoding Rna RegulationLong Noncoding Rna-mediated Apoptosis ControlNoncoding Rna Expression ProfilingNoncoding Rna In ApoptosisP53-mediated Cell Cycle RegulationP53-mediated Cell-cycle Control
// Nithyananda Thorenoor 1 , Petra Faltejskova-Vychytilova 1, 2 , Sonja Hombach 3 , Jitka Mlcochova 1 , Markus Kretz 3 , Marek Svoboda 2 , Ondrej Slaby 1, 2 1 Central European Institute of Technology, Masaryk University, 62500 Brno, Czech Republic 2 Masaryk Memorial Cancer Institute, Department of Comprehensive Cancer Care, 65653 Brno, Czech Republic 3 Institute of Biochemistry, Genetics and Microbiology, University of Regensburg, Regensburg, 93053, Germany Correspondence to: Ondrej Slaby, e-mail: on.slaby@gmail.com Keywords: colorectal cancer, lncRNA, ZFAS1, CDK1 Received: July 29, 2015 Accepted: October 06, 2015 Published: October 19, 2015 ABSTRACT We determined expression of 83 long non-coding RNAs (lncRNAs) and identified ZFAS1 to be significantly up-regulated in colorectal cancer (CRC) tissue. In cohort of 119 CRC patients we observed that 111 cases displayed at least two-times higher expression of ZFAS1 in CRC compared to paired normal colorectal tissue ( P < 0.0001). By use of CRC cell lines (HCT116+/+, HCT116−/− and DLD-1) we showed, that ZFAS1 silencing decreases proliferation through G1-arrest of cell cycle, and also tumorigenicity of CRC cells. We identified Cyclin-dependent kinase 1 (CDK1) as interacting partner of ZFAS1 by pull-down experiment and RNA immunoprecipitation. Further, we have predicted by bioinformatics approach ZFAS1 to sponge miR-590-3p, which was proved to target CDK1. Levels of CDK1 were not affected by ZFAS1 silencing, but cyclin B1 was decreased in both cell lines. We observed significant increase in p53 levels and PARP cleavage in CRC cell lines after ZFAS1 silencing indicating increase in apoptosis. Our data suggest that ZFAS1 may function as oncogene in CRC by two main actions: (i) via destabilization of p53 and through (ii) interaction with CDK1/cyclin B1 complex leading to cell cycle progression and inhibition of apoptosis. However, molecular mechanisms behind these interactions have to be further clarified.
11
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Leonardo Salmena, Laura Poliseno, Yvonne Tay et al. · Cell · 2011 · 7.7K citations · Full text